All In MedTech

Device Trial Radar · NCT07030322

Health and Financial Impact on the Use of a Personal Exoskeleton in the Home and Community: a Case Study

Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

5

Planned (sponsor's estimate)

Start

Aug 4, 2025

Primary completion

Sep 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Ekso BionicsNot on our public-company list
Sponsor type
Industry
First posted
Jun 22, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to examine the long-term use of a personal overground robotic exoskeleton in subjects with spinal cord injury. The main aims of this study include: 1. Determine patterns of personal overground robotic exoskeleton use over 12 months. 2. Examine the impact of personal overground robotic exoskeleton use on health outcomes over 12 months. These will include: 1. Objective health - heart rate, physical activity, sleep behavior, body temperature, body-mass index, and bone density 2. Medical status - rehospitalization, infection frequency, pressure injury, falls, fractures, medication (type/dose) 3. Function - bowel function, bladder function, pain, spasticity, quality of life, mental health, social participation 3. Determine healthcare expenditure over 12 months Participants and their support person(s) will be trained on using a personal robotic exoskeleton in their home and community. Once they complete training, they will use the exoskeleton as they wish (ie, no requirement to use the device a certain number of times per week) and data collection will begin.

Conditions

  • Spinal Cord Injury

Interventions

  • Overground Robotic ExoskeletonDevice

    Participants will have received training on their personal exoskeleton device prior to data collection. There is no required use dosage of the Ekso Indego Personal for this observational study.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in sessions recorded and provided by the exoskeleton device across study timepointsTime frame: baseline, 1-month post-enrollment, 3-months post-enrollment, 6-months post-enrollment, and 12-months post-enrollment.
  2. Change in time spent walking recorded and provided by the exoskeleton device across study timepointsTime frame: baseline, 1-month post-enrollment, 3-months post-enrollment, 6-months post-enrollment, and 12-months post-enrollment.
  3. Change in walking time recorded and provided by the exoskeleton device across study timepointsTime frame: baseline, 1-month post-enrollment, 3-months post-enrollment, 6-months post-enrollment, and 12-months post-enrollment.

12 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ekso Bionics, Inc.

    San Rafael, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.